Comparison of montelukast versus budesonide in the treatment of exercise-induced bronchoconstriction
- 30 June 2001
- journal article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 86 (6) , 655-658
- https://doi.org/10.1016/s1081-1206(10)62294-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstrictionJournal of Allergy and Clinical Immunology, 1999
- Effect of Long-Term Salmeterol Treatment on Exercise-Induced AsthmaNew England Journal of Medicine, 1998
- Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced BronchoconstrictionNew England Journal of Medicine, 1998
- Exercise-induced asthma: Update on pathophysiology, clinical diagnosis, and treatmentCurrent Problems in Pediatrics, 1997
- Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment.American Journal of Respiratory and Critical Care Medicine, 1995
- Role of Leukotrienes in Exercise-induced Asthma: Inhibitory Effect of ICI 204219, a Potent Leukotriene D4Receptor AntagonistAmerican Review of Respiratory Disease, 1992
- Exercise-induced asthma is not associated with mast cell activation or airway inflammationJournal of Allergy and Clinical Immunology, 1992
- Effect of inhaled budesonide on bronchial reactivity to histamine, exercise, and eucapnic dry air hyperventilation in patients with asthma.Thorax, 1991
- Inhibition of Exercise-Induced Bronchoconstriction by MK-571, a Potent Leukotriene D4–Receptor AntagonistNew England Journal of Medicine, 1990
- Airway Levels of Mast Cell—derived Mediators in Exercise-induced AsthmaAmerican Review of Respiratory Disease, 1990